INVO Fertility Files 8-K with Financials
Ticker: IVF · Form: 8-K · Filed: Aug 15, 2025 · CIK: 1417926
Sentiment: neutral
Topics: financial-reporting, 8-k
TL;DR
INVO Fertility dropped its 8-K on Aug 14th - check financials!
AI Summary
On August 14, 2025, INVO Fertility, Inc. filed an 8-K report detailing its financial results and operations. The company, formerly known as NAYA Biosciences, Inc., is incorporated in Nevada and operates in the surgical and medical instruments sector. The filing includes financial statements and exhibits, with its principal business address located in Sarasota, Florida.
Why It Matters
This filing provides investors with crucial updates on INVO Fertility's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing reporting financial information, not indicating any immediate adverse events.
Key Players & Entities
- INVO Fertility, Inc. (company) — Registrant
- NAYA Biosciences, Inc. (company) — Former company name
- August 14, 2025 (date) — Date of earliest event reported
- Sarasota, FL (location) — Business address
FAQ
What is the primary purpose of this 8-K filing for INVO Fertility, Inc.?
The primary purpose of this 8-K filing is to report on INVO Fertility, Inc.'s Results of Operations and Financial Condition, as well as to provide Financial Statements and Exhibits.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on August 14, 2025.
What was INVO Fertility, Inc. formerly known as?
INVO Fertility, Inc. was formerly known as NAYA Biosciences, Inc., with a name change effective October 22, 2024.
In which state is INVO Fertility, Inc. incorporated?
INVO Fertility, Inc. is incorporated in Nevada.
What is the business address of INVO Fertility, Inc.?
The business address of INVO Fertility, Inc. is 5582 Broadcast Court, Sarasota, FL 34240.
Filing Stats: 519 words · 2 min read · ~2 pages · Grade level 10 · Accepted 2025-08-15 14:03:10
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
Filing Documents
- form8-k.htm (8-K) — 37KB
- ex99-1.htm (EX-99.1) — 74KB
- 0001641172-25-024338.txt ( ) — 281KB
- ivf-20250814.xsd (EX-101.SCH) — 3KB
- ivf-20250814_lab.xml (EX-101.LAB) — 33KB
- ivf-20250814_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: August 15, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer -3-